Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4210 reports available
All reports
Page 117 of 141
Daily Points
Scotiabank · May 14, 2026
Daily Asia: Position for Transformational Innovation
UBS · May 14, 2026
AI Exposure and Growth Outlook
UBS · May 14, 2026
Economic Implications of a Change in Prime Minister
Berenberg · May 14, 2026
Hedge Fund Monthly Update
Bank of America · May 14, 2026
Markets Today
Bank of New Zealand · May 14, 2026
Pause for Breath, Siemens Upgrades
J.P. Morgan · May 14, 2026
First Take: Alibaba Health 2H FY26 Results
Goldman Sachs · May 14, 2026
US Equities Mid-Day Color
Goldman Sachs & Co. LLC · May 14, 2026
US Morning Call
Goldman Sachs · May 14, 2026
Thoughts From Veeam's Investor Session
RBC Capital Markets · May 14, 2026
ADES Expanded Global Offshore Platform Yields Diversification Benefits
Goldman Sachs · May 14, 2026
April 2026 Office REITs Update
Goldman Sachs · May 14, 2026
Allogene Therapeutics Look to First Autoimmune CAR T Data in 4Q
Goldman Sachs · May 14, 2026
Allegro 1Q26 Results and FY26 Outlook Upgrade
Goldman Sachs · May 14, 2026
Macro Uncertainty's Economic Effects
PGIM · May 13, 2026
Weekly Investor Research
Ashmore · May 13, 2026
Early Morning Reid
Deutsche Bank AG · May 13, 2026
Nemluvio Navigator Strong Prescription Trends Support Blockbuster Run Rate Guide
Goldman Sachs · May 13, 2026
Galaxy Entertainment Group 1Q26 Results Update
Goldman Sachs · May 13, 2026
Spring Forward
TPL Advisory · May 13, 2026
New Zealand Morning Focus
ANZ · May 13, 2026
Australian Morning Focus
ANZ · May 13, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · May 13, 2026